PNW Headlines
Home » Archives for January 2019

Month: January 2019

WednesdayJan 30, 2019 9:00 am

Outside Investment, New Technology Support Growing Cannabis Industry

PsychedelicNewsWire Editorial Coverage: Revolutionary innovations and advancements within the cannabis industry are drawing significant investment from big corporations. Technology currently in development will make it easier to consume active ingredients in cannabis. Advances have attracted investment for the technology’s use in tobacco as well as cannabis. These improvements could move consumers to healthier forms of consumption than smoking. Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) (LXRP Profile) has benefited from recent investment by Altria to support its innovative research and design work. Canopy Growth Corporation (NYSE: CGC) (TSX: WEED) has received substantial investment from a beverage company, which will support…

Continue Reading

TuesdayJan 29, 2019 12:53 pm

Buyer Beware: Why You Can’t Always Trust CBD Product Labels

American consumers may have gotten used to the old adage “what you see is what you get” when it comes to ingredient labels. While most CBD companies create a reliable product, some studies have shown that certain companies’ CBD product labels either under-represent or over-represent the amount of CBD contained within. While this issue is not an epidemic, it is cause for further education on CBD product labels, so you can be an informed consumer. What’s Going On With CBD Products? From 2015 to 2017 the FDA sent 44 warning letters to CBD companies, some multiple times, whose labels were…

Continue Reading

ThursdayJan 24, 2019 11:37 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Acquires a $12 Million Investor

Lexaria Nicotine LLC partners with one of the world’s largest tobacco companies Opportunity to change nicotine delivery and improve the lives of millions Retains ownership of DehydraTECH while licensing the technology out to multiple industries Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) recently announced that its wholly owned subsidiary, Lexaria Nicotine LLC, has partnered with one of the world’s largest tobacco companies to fund the research and development of Lexaria’s patented DehydraTECH (http://cnw.fm/w86Vf). The partnership may potentially commercialize this cutting-edge technology for oral nicotine delivery. Chris Bunka, CEO of Lexaria Bioscience, is excited about the opportunity to work with a world-class…

Continue Reading

WednesdayJan 16, 2019 9:00 am

New Laws Set Up US Cannabis Industry for Explosive Growth

PsychedelicNewsWire Editorial Coverage: The 2018 U.S. Farm Bill changes the way that CBD-based products are legally classified. If the federal government permits the sale of cannabis-sourced products online, established companies in the space could reap huge rewards. The legalization of cannabis in Canada and some U.S. States has demonstrated the latent demand for cannabis-based products. CBD is used to make numerous products and its potential uses are growing. Research suggests that the market for CBD products could grow to an estimated $22 billion over the next four years. SinglePoint Inc. (OTCQB: SING) (SING Profile) is in a good position to…

Continue Reading

FridayJan 11, 2019 11:10 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) CEO Discusses Company Initiatives at O’Cannabiz 2018

Lexaria Bioscience has its innovative DehydraTECH drug delivery platform The company’s DehydraTECH technology is complementary to other R&D being done on cannabinoids Lexaria recently attended O’Cannabiz 2018 in Vancouver A biotech company, Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) offers a unique platform that makes it possible to deliver bioactive substances through oral ingestion. Its DehydraTECH technology accomplishes this without the need for unhealthy inhalational dosing. DehydraTECH uses only GRAS (Generally Recognized as Safe) ingredients and increases bio-absorption by five to 10 times. Based in Kelowna, British Columbia, Lexaria Bioscience is the only company globally with patents issued for the…

Continue Reading

PsychedelicNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 415.949.5050

PsychedelicNewsWire
PsychedelicNewsWire

1728 Ocean Ave
Suite PNW-276
San Francisco, CA 94112
(415) 949-5050

Copyright © . PsychedelicNewsWire / 1728 Ocean Ave, Suite PNW-276, San Francisco, CA 94112 (415) 949-5050 / Disclaimers